Boiron SA
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Boiron SA
Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company’s products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.
/ 
Frequently asked questions
To buy Boiron SA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Boiron SA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Boiron SA is BOI:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Boiron SA has its primary listing on Euronext Paris. You can trade Boiron SA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Boiron SA is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Boiron SA as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Boiron SA.